The independent source for health policy research, polling, and news.
261 - 280 of 738 Results
More than 10,000 dental patients have been fitted with an Anterior Growth Guidance Appliance, or AGGA, according to court records. But the unproven and unregulated device has not been evaluated by the FDA, according to a months-long joint investigation by KHN and CBS News.
More than 200 inmates killed themselves during eight years in which state prison officials failed to complete court-ordered suicide prevention safeguards. Inmates, the judge writes, have “waited far too long” for adequate mental health care.
A dental device called AGGA has been used on about 10,000 patients without FDA approval or proof that it works. In lawsuits, patients report irreparable harm. The AGGA’s inventor and manufacturer have denied all liability in court.
“What happens in Texas doesn't stay in Texas,” warns an abortion rights advocate bracing for a district judge’s ruling on whether the abortion pill mifepristone was properly authorized by the FDA. His decision could force the medication off the U.S. market.
Patients who depend upon special drugs to treat rare diseases are caught in the crossfire as drugmakers and the FDA battle over regulations that reward companies for developing treatments for relatively small pools of patients.
After the BP Deepwater Horizon oil spill in 2020, Rodney Boblitt's job was to patrol a 14-mile stretch of coastline in the Florida Panhandle looking for signs of oil washing ashore. Today, the 54-year-old is among thousands of other cleanup workers who are experiencing health issues and suing BP. But proving their health conditions were caused by the oil has been challenging.
Lawmakers in 14 states have passed near-total bans on abortion since the U.S. Supreme Court overturned Roe v. Wade. But in some conservative-led states where court rulings determined their constitutions protect abortion, including Montana, politicians haven’t asked voters to weigh in.
President Joe Biden’s 2023 State of the Union address leaned heavily on health care issues. Biden took a victory lap for recent accomplishments like capping prescription drug costs for seniors on Medicare. He also urged Congress to make permanent the boosted premium subsidies under the Affordable Care Act, and he sparred with Republicans on threats to cut Social Security and Medicare. Also this week, both sides in the abortion debate are bracing for a court decision out of Texas that could, at least temporarily, make the abortion pill mifepristone illegal nationwide. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KHN chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Kate Baicker of the University of Chicago about a possible middle ground in the effort to get universal health insurance coverage.
The nation’s largest Medicaid insurer denies wrongdoing after the California attorney general’s office investigated it for inflating prescription drug costs.
The online women’s pharmacy agreed to pay $15 million to the state Department of Justice and $3.3 million to the Department of Insurance over claims it overbilled Medi-Cal.
In Part II of this special two-part episode, Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Sarah Varney of KHN join KHN chief Washington correspondent Julie Rovner to discuss how the abortion debate has evolved since the Supreme Court overturned the nationwide right to abortion in 2022, and what might be the flashpoints for 2023. Also, for extra credit, the panelists recommend their most memorable reproductive health stories from the last year.
In Part I of this special two-part episode, Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Sarah Varney of KHN join KHN chief Washington correspondent Julie Rovner to discuss how the abortion debate has evolved since the Supreme Court overturned the nationwide right to abortion in 2022, and what might be the flashpoints for 2023. Also in this episode, Rovner interviews Elizabeth Nash of the Guttmacher Institute, about changing reproductive policies in the states.
On the 50th anniversary of Roe v. Wade, we asked people across the U.S. what the abrupt upending of abortion rights has meant to them, and we lay out the stakes in the battles ahead.
Montana officials are looking to tighten rules around medically necessary abortions for those who use Medicaid as their health insurance. Reproductive health advocates and Democratic lawmakers have said the move is part of a broader agenda to whittle away access to the procedure.
Friday’s annual March for Life rally in Washington, D.C., held for the first time since Roe v. Wade was overturned, signals a new chapter in the anti-abortion movement.
Abortion is a top issue for state lawmakers meeting for their first full sessions since Roe v. Wade was overturned.
Anti-abortion candidates have fared well in recent elections. But decades of ballot initiatives — including a half-dozen measures considered after the Supreme Court overturned Roe v. Wade last June — show that when voters are asked directly, they usually side with preserving abortion rights.
California Attorney General Rob Bonta is taking three major drugmakers and three distributors to court, alleging the companies illegally raised prices at the expense of diabetes patients.
How one Louisiana woman experiencing a miscarriage sought care amid a climate of fear and confusion among doctors fueled by that state’s restrictive abortion law.
An investigation of records from 25 county jails across Pennsylvania showed that nearly 1 in 3 "use of force" incidents by guards involved a confined person who was having a psychiatric crisis or who had a known mental illness.
© 2026 KFF